• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心原性休克表型。

Phenotyping Cardiogenic Shock.

机构信息

The CardioVascular Center Tufts Medical Center Boston MA.

Medical Faculty Heinrich Heine University Düsseldorf Germany.

出版信息

J Am Heart Assoc. 2021 Jul 20;10(14):e020085. doi: 10.1161/JAHA.120.020085. Epub 2021 Jul 6.

DOI:10.1161/JAHA.120.020085
PMID:34227396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8483502/
Abstract

Background Cardiogenic shock (CS) is a heterogeneous syndrome with varied presentations and outcomes. We used a machine learning approach to test the hypothesis that patients with CS have distinct phenotypes at presentation, which are associated with unique clinical profiles and in-hospital mortality. Methods and Results We analyzed data from 1959 patients with CS from 2 international cohorts: CSWG (Cardiogenic Shock Working Group Registry) (myocardial infarction [CSWG-MI; n=410] and acute-on-chronic heart failure [CSWG-HF; n=480]) and the DRR (Danish Retroshock MI Registry) (n=1069). Clusters of patients with CS were identified in CSWG-MI using the consensus k means algorithm and subsequently validated in CSWG-HF and DRR. Patients in each phenotype were further categorized by their Society of Cardiovascular Angiography and Interventions staging. The machine learning algorithms revealed 3 distinct clusters in CS: "non-congested (I)", "cardiorenal (II)," and "cardiometabolic (III)" shock. Among the 3 cohorts (CSWG-MI versus DDR versus CSWG-HF), in-hospital mortality was 21% versus 28% versus 10%, 45% versus 40% versus 32%, and 55% versus 56% versus 52% for clusters I, II, and III, respectively. The "cardiometabolic shock" cluster had the highest risk of developing stage D or E shock as well as in-hospital mortality among the phenotypes, regardless of cause. Despite baseline differences, each cluster showed reproducible demographic, metabolic, and hemodynamic profiles across the 3 cohorts. Conclusions Using machine learning, we identified and validated 3 distinct CS phenotypes, with specific and reproducible associations with mortality. These phenotypes may allow for targeted patient enrollment in clinical trials and foster development of tailored treatment strategies in subsets of patients with CS.

摘要

背景 心原性休克(CS)是一种表现和结局多样的异质性综合征。我们采用机器学习方法检验了以下假设,即 CS 患者在就诊时具有不同的表型,这些表型与独特的临床特征和院内死亡率相关。

方法和结果 我们分析了来自 2 个国际队列的 1959 例 CS 患者的数据:CSWG(心原性休克工作组注册)(心肌梗死 [CSWG-MI;n=410] 和急性加重的慢性心力衰竭 [CSWG-HF;n=480])和 DRR(丹麦再休克 MI 注册)(n=1069)。在 CSWG-MI 中使用共识 k 均值算法识别 CS 患者的聚类,随后在 CSWG-HF 和 DRR 中进行验证。在每个表型中,患者进一步根据心血管造影和介入学会的分期进行分类。机器学习算法在 CS 中揭示了 3 个不同的聚类:“非充血性(I)”、“心肾(II)”和“心代谢(III)”休克。在 3 个队列(CSWG-MI 与 DDR 与 CSWG-HF)中,院内死亡率分别为 21%对 28%对 10%、45%对 40%对 32%、55%对 56%对 52%,分别为聚类 I、II 和 III。“心代谢性休克”聚类在表型中具有发展为 D 期或 E 期休克以及院内死亡率最高的风险,无论病因如何。尽管存在基线差异,但每个聚类在 3 个队列中都表现出可重复的人口统计学、代谢和血液动力学特征。

结论 使用机器学习,我们鉴定并验证了 3 种不同的 CS 表型,与死亡率具有明确和可重复的关联。这些表型可能有助于在临床试验中针对特定患者进行入组,并促进 CS 亚组患者的个体化治疗策略的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8483502/8f59ff5830cf/JAH3-10-e020085-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8483502/67e4722ae180/JAH3-10-e020085-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8483502/c5a450daf3e2/JAH3-10-e020085-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8483502/698b4fbc808f/JAH3-10-e020085-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8483502/8f59ff5830cf/JAH3-10-e020085-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8483502/67e4722ae180/JAH3-10-e020085-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8483502/c5a450daf3e2/JAH3-10-e020085-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8483502/698b4fbc808f/JAH3-10-e020085-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8483502/8f59ff5830cf/JAH3-10-e020085-g004.jpg

相似文献

1
Phenotyping Cardiogenic Shock.心原性休克表型。
J Am Heart Assoc. 2021 Jul 20;10(14):e020085. doi: 10.1161/JAHA.120.020085. Epub 2021 Jul 6.
2
Application of Cardiogenic Shock Working Group-defined Society for Cardiovascular Angiography and Interventions (CSWG-SCAI) Staging of Cardiogenic Shock to the Medical Information Mart for Intensive Care IV (MIMIC-IV) database.将心源性休克工作组定义的心血管造影和介入学会(CSWG-SCAI)心源性休克分期应用于重症监护医学信息集市IV(MIMIC-IV)数据库。
Cardiovasc Revasc Med. 2023 Dec;57:82-90. doi: 10.1016/j.carrev.2023.06.019. Epub 2023 Jun 23.
3
Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic Shock.对心源性休克患者进行有创血流动力学评估和院内死亡率风险分类。
Circ Heart Fail. 2020 Sep;13(9):e007099. doi: 10.1161/CIRCHEARTFAILURE.120.007099. Epub 2020 Sep 9.
4
Clinical Course of Patients in Cardiogenic Shock Stratified by Phenotype.根据表型分层的心源性休克患者的临床病程
JACC Heart Fail. 2023 Oct;11(10):1304-1315. doi: 10.1016/j.jchf.2023.05.007. Epub 2023 Jun 21.
5
Association of Hemometabolic Trajectory and Mortality: Insights From the Cardiogenic Shock Working Group Registry.血液代谢轨迹与死亡率的关联:来自心原性休克工作组注册研究的新见解。
J Card Fail. 2024 Oct;30(10):1196-1207. doi: 10.1016/j.cardfail.2024.06.019.
6
Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality.肺动脉导管进行完全血流动力学分析与心源性休克患者院内死亡率降低相关。
JACC Heart Fail. 2020 Nov;8(11):903-913. doi: 10.1016/j.jchf.2020.08.012.
7
Outcomes of Patients Transferred to Tertiary Care Centers for Treatment of Cardiogenic Shock: A Cardiogenic Shock Working Group Analysis.因心原性休克转至三级医疗中心治疗的患者的结局:心原性休克工作组分析。
J Card Fail. 2024 Apr;30(4):564-575. doi: 10.1016/j.cardfail.2023.09.003. Epub 2023 Oct 9.
8
Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock.心力衰竭和心源性休克的临床特征和住院过程。
JACC Heart Fail. 2023 Feb;11(2):176-187. doi: 10.1016/j.jchf.2022.10.002. Epub 2022 Oct 31.
9
Serial Shock Severity Assessment Within 72 Hours After Diagnosis: A Cardiogenic Shock Working Group Report.诊断后72小时内的连续休克严重程度评估:心源性休克工作组报告。
J Am Coll Cardiol. 2024 Aug 1. doi: 10.1016/j.jacc.2024.04.069.
10
Sex Differences in Characteristics, Resource Utilization, and Outcomes of Cardiogenic Shock: Data From the Critical Care Cardiology Trials Network (CCCTN) Registry.心源性休克患者的特征、资源利用和结局的性别差异:来自重症心脏病学临床试验网络(CCCTN)注册研究的数据。
Circ Cardiovasc Qual Outcomes. 2024 Aug;17(8):e010614. doi: 10.1161/CIRCOUTCOMES.123.010614. Epub 2024 Jun 20.

引用本文的文献

1
Cardiogenic shock: diagnosis, phenotyping and management.心源性休克:诊断、分型及管理
Intensive Care Med. 2025 Aug 6. doi: 10.1007/s00134-025-08049-y.
2
Invasive Hemodynamic Monitoring in Acute Heart Failure and Cardiogenic Shock.急性心力衰竭和心源性休克的有创血流动力学监测
Rev Cardiovasc Med. 2025 Jun 19;26(6):27034. doi: 10.31083/RCM27034. eCollection 2025 Jun.
3
Right ventricular-pulmonary coupling and tissue hypoperfusion: a combined echocardiographic and metabolic approach to prognosticate cardiogenic shock.

本文引用的文献

1
Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic Shock.对心源性休克患者进行有创血流动力学评估和院内死亡率风险分类。
Circ Heart Fail. 2020 Sep;13(9):e007099. doi: 10.1161/CIRCHEARTFAILURE.120.007099. Epub 2020 Sep 9.
2
The SCAI Cardiogenic Shock Staging System Gets Taken for a Test Drive.SCAI心源性休克分期系统进行了试运行。
J Am Coll Cardiol. 2019 Oct 29;74(17):2129-2131. doi: 10.1016/j.jacc.2019.08.1020. Epub 2019 Sep 20.
3
Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit.
右心室-肺血管耦合与组织灌注不足:一种结合超声心动图和代谢方法预测心源性休克。
BMC Cardiovasc Disord. 2025 Jul 3;25(1):453. doi: 10.1186/s12872-025-04904-4.
4
AI-Based Predictive Models for Cardiogenic Shock in STEMI: Real-World Data for Early Risk Assessment and Prognostic Insights.基于人工智能的ST段抬高型心肌梗死心源性休克预测模型:早期风险评估和预后洞察的真实世界数据
J Clin Med. 2025 May 25;14(11):3698. doi: 10.3390/jcm14113698.
5
The Effect of Vasopressin on 90-Day Mortality in Patients With Cardiogenic Shock: A Retrospective Cohort Study Using Propensity Score-Weighted Analysis.血管加压素对心源性休克患者90天死亡率的影响:一项使用倾向评分加权分析的回顾性队列研究。
Cardiovasc Ther. 2025 May 28;2025:9920490. doi: 10.1155/cdr/9920490. eCollection 2025.
6
Temporary Mechanical Support in Cardiogenic Shock Secondary to Heart Failure: An Evolving Paradigm.心力衰竭所致心源性休克的临时机械支持:一种不断演变的模式。
J Pers Med. 2025 May 2;15(5):184. doi: 10.3390/jpm15050184.
7
Clinical phenotyping of cardiogenic shock at a glance: A rapid, costless, streamlined approach.心源性休克的临床表型速览:一种快速、低成本、简化的方法。
ESC Heart Fail. 2025 May 19;12(4):3183-6. doi: 10.1002/ehf2.15336.
8
Comparison of different AI systems for diagnosing sepsis, septic shock, and cardiogenic shock: a retrospective study.用于诊断脓毒症、脓毒性休克和心源性休克的不同人工智能系统的比较:一项回顾性研究。
Sci Rep. 2025 May 6;15(1):15850. doi: 10.1038/s41598-025-00830-9.
9
Kidney replacement therapy during extracorporeal membrane oxygenation: pathophysiology, technical considerations, and outcomes.体外膜肺氧合期间的肾脏替代治疗:病理生理学、技术考量及结果
Ren Fail. 2025 Dec;47(1):2486557. doi: 10.1080/0886022X.2025.2486557. Epub 2025 Apr 23.
10
Evolution of Critical Care Cardiology: An Update on Structure, Care Delivery, Training, and Research Paradigms: A Scientific Statement From the American Heart Association.危重症心脏病学的发展:结构、护理提供、培训及研究范式的最新进展:美国心脏协会科学声明
J Am Coll Cardiol. 2025 Jul 29;86(4):291-313. doi: 10.1016/j.jacc.2025.02.002. Epub 2025 Apr 18.
心原性休克分类预测心脏重症监护病房死亡率。
J Am Coll Cardiol. 2019 Oct 29;74(17):2117-2128. doi: 10.1016/j.jacc.2019.07.077. Epub 2019 Sep 20.
4
Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.近期诊断糖尿病患者亚组中糖尿病相关疾病的风险:一项为期 5 年的随访研究。
Lancet Diabetes Endocrinol. 2019 Sep;7(9):684-694. doi: 10.1016/S2213-8587(19)30187-1. Epub 2019 Jul 22.
5
Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study.2010 年至 2017 年急性心肌梗死后心源性休克的发病率和患者特征的时间趋势:丹麦队列研究。
Eur J Heart Fail. 2019 Nov;21(11):1370-1378. doi: 10.1002/ejhf.1566. Epub 2019 Jul 24.
6
Management of cardiogenic shock complicating myocardial infarction: an update 2019.心肌梗死并发心源性休克的治疗:2019 年更新
Eur Heart J. 2019 Aug 21;40(32):2671-2683. doi: 10.1093/eurheartj/ehz363.
7
SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019.美国心脏病学会(ACC)、美国心脏协会(AHA)、重症医学会(SCCM)和胸外科医师学会(STS)于 2019 年 4 月共同发布了心血管造影协会(SCAI)关于心源性休克分类的临床专家共识声明。
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):29-37. doi: 10.1002/ccd.28329. Epub 2019 May 19.
8
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis.新型败血症临床表型的推导、验证及潜在治疗意义。
JAMA. 2019 May 28;321(20):2003-2017. doi: 10.1001/jama.2019.5791.
9
Venoarterial Extracorporeal Membrane Oxygenation for Cardiopulmonary Support.用于心肺支持的静脉-动脉体外膜肺氧合
Circulation. 2018 Nov 13;138(20):2298-2300. doi: 10.1161/CIRCULATIONAHA.118.036691.
10
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables.基于六个变量的聚类分析:成人发病型糖尿病的新型亚组及其与结局的关系
Lancet Diabetes Endocrinol. 2018 May;6(5):361-369. doi: 10.1016/S2213-8587(18)30051-2. Epub 2018 Mar 5.